Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Phillips
Tim Clark

Pharmaceutical statistics

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pharmaceutical Statistics|September 7, 2020
Estimands in practice: Bridging the gap between study objectives and statistical analysisAlan Phillips, Tim Clark
Pharmaceutical Statistics|December 27, 2022
Improving early phase oncology clinical trial design: An opportunity for statisticiansAlan Phillips, Shalini Mondal
Pharmaceutical Statistics|January 20, 2023
Improving early phase oncology clinical trial design: The case for finding the optimal biological doseAlan Phillips, Shalini Mondal
Pharmaceutical Statistics|November 30, 2022
Web based resource for Statistical Consultants in the Pharmaceutical IndustryAlan Phillips, Karen Smith
Pharmaceutical Statistics|September 12, 2007
Conditional approval: discussion points from the PSI conditional approval expert groupKevin Carroll, Hilary Chaudri Ross, Dan Evans, et al.
Pharmaceutical Statistics|July 30, 2013
Multiplicity: discussion points from the Statisticians in the Pharmaceutical Industry multiplicity expert groupAlan Phillips, Chrissie Fletcher, Gary Atkinson, et al.
Pharmaceutical Statistics|March 22, 2016
Estimands: discussion points from the PSI estimands and sensitivity expert groupAlan Phillips, Juan Abellan-Andres, Andersen Soren, et al.
Pharmaceutical Statistics|October 22, 2009
Missing data: discussion points from the PSI missing data expert groupTomasz Burzykowski, James Carpenter, Corneel Coens, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmaceutical Statistics|September 7, 2020
Estimands in practice: Bridging the gap between study objectives and statistical analysisAlan Phillips, Tim Clark
Pharmaceutical Statistics|December 27, 2022
Improving early phase oncology clinical trial design: An opportunity for statisticiansAlan Phillips, Shalini Mondal
Pharmaceutical Statistics|January 20, 2023
Improving early phase oncology clinical trial design: The case for finding the optimal biological doseAlan Phillips, Shalini Mondal
Pharmaceutical Statistics|November 30, 2022
Web based resource for Statistical Consultants in the Pharmaceutical IndustryAlan Phillips, Karen Smith
Pharmaceutical Statistics|September 12, 2007
Conditional approval: discussion points from the PSI conditional approval expert groupKevin Carroll, Hilary Chaudri Ross, Dan Evans, et al.
Pharmaceutical Statistics|July 30, 2013
Multiplicity: discussion points from the Statisticians in the Pharmaceutical Industry multiplicity expert groupAlan Phillips, Chrissie Fletcher, Gary Atkinson, et al.
Pharmaceutical Statistics|March 22, 2016
Estimands: discussion points from the PSI estimands and sensitivity expert groupAlan Phillips, Juan Abellan-Andres, Andersen Soren, et al.
Pharmaceutical Statistics|October 22, 2009
Missing data: discussion points from the PSI missing data expert groupTomasz Burzykowski, James Carpenter, Corneel Coens, et al.
Pageof 1